Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Robert Landry
Age : 57
Public asset : 19,096,394 USD
Country of residence : Unknown
Linked companies : Regeneron Pharmaceuticals, Inc.

Biography of Robert Landry 
Robert E. Landry is Chief Financial Officer & Executive VP-Finance at Regeneron Pharmaceuticals, Inc. He previously was Treasurer & Senior Vice President at Pfizer Inc. Director-Pharmaceutical Marketing & Sales at Wyeth Australia Pty Ltd. Chief Financial Officer of Wyeth New Zealand and Treasurer & Principal Corporate Officer at Wyeth Corp. (which are all subsidiaries of Pfizer Inc.). Mr. Landry received an undergraduate degree from the University of Notre Dame.


Current positions of Robert Landry 
Holdings of Robert Landry 
Robert Landry : Personal Network 
Most Read News 
05/20XAVIER NIEL : UWR shares spike as billionaire Xavier Niel discloses 27% stake
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/24ELON MUSK : In a faceoff with Elon Musk, the SEC blinked
RE
05/19ELON MUSK : Musk says 'Tesla is on my mind 24/7' amid concerns about Twitter distraction
RE
05/17ELON MUSK : Prominent hedge funds invested in Twitter before Musk unveiled plans
RE
05/25ELON MUSK : Twitter investors vote against re-electing Elon Musk ally to board
RE
01:36aELON MUSK : Musk sued by Twitter investors for stock 'manipulation' during takeover bid
RE
05/23HOCK TAN : Chipmaker Broadcom in talks to acquire VMware for $60 billion -sources
RE
05/17JPMorgan shareholders vote disapproval of CEO Dimon's special payout
RE
05/12ELON MUSK : Twitter CEO says two leaders to depart, hiring paused amid Musk takeover
RE
More news


© 2022 People and Ownership :   
Robert Landry : Connections 


Latest news about Robert Landry 
05/10TRANSCRIPT : Regeneron Pharmaceuticals, Inc. Presents at Bank of America 2022 Healthcare Conference, May-10-2022 01:20 PM
CI
05/04TRANSCRIPT : Regeneron Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 04, 2022
CI
03/16TRANSCRIPT : Regeneron Pharmaceuticals, Inc. Presents at Barclays Global Healthcare Conference 2022, Mar-16-2022 08:00 AM
CI
03/08TRANSCRIPT : Regeneron Pharmaceuticals, Inc. Presents at 42nd Annual Cowen Health Care Conference, Mar-08-2022 01:30 PM
CI
02/04Regeneron Beats Fourth-Quarter Views, Expects No COVID-19 Drug's US Sales in First Half
MT
02/04TRANSCRIPT : Regeneron Pharmaceuticals, Inc., Q4 2021 Earnings Call, Feb 04, 2022
CI
2021TRANSCRIPT : Regeneron Pharmaceuticals, Inc. Presents at Piper Sandler 33rd Annual Virtual Healthcare Conference, Dec-01-2021 08:00 AM
CI
More news